Covered recipient · General Payments record
STEPHANIE BERNSTEIN
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$678,430.00
- Reported across 95 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $56,280.00 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| AstraZeneca UK Limited | $40,040.00 | 10 |
| BeiGene, Ltd. | $16,240.00 | 6 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca UK Limited | $495.00 | 01/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094019221 | CMS |
| AstraZeneca UK Limited | $10,065.00 | 02/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093976900 | CMS |
| AstraZeneca UK Limited | $11,605.00 | 03/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094011370 | CMS |
| AstraZeneca UK Limited | $4,950.00 | 04/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094025112 | CMS |
| AstraZeneca UK Limited | $220.00 | 05/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094027362 | CMS |
| AstraZeneca UK Limited | $110.00 | 06/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093972052 | CMS |
| AstraZeneca UK Limited | $1,925.00 | 08/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093969915 | CMS |
| AstraZeneca UK Limited | $1,210.00 | 09/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093940422 | CMS |
| AstraZeneca UK Limited | $770.00 | 11/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093912145 | CMS |
| AstraZeneca UK Limited | $8,690.00 | 12/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093994050 | CMS |
| BeiGene, Ltd. | $300.00 | 08/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120860819 | CMS |
| BeiGene, Ltd. | $2,045.00 | 08/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120860823 | CMS |
| BeiGene, Ltd. | $9,060.00 | 09/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120860827 | CMS |
| BeiGene, Ltd. | $250.00 | 10/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120860817 | CMS |
| BeiGene, Ltd. | $3,205.00 | 11/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120860825 | CMS |
| BeiGene, Ltd. | $1,380.00 | 12/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120860821 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.